Navigation Links
NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs
Date:7/6/2009

inology. Previously he served as Chief Medical Officer at Manhattan Pharmaceuticals, Inc., after serving as Therapeutic Head of the Worldwide Medical Endocrine Care group at Pfizer Inc, New York and, earlier, as Vice President, Global Healthcare Research & Outcomes and Senior Director of Medical & Scientific Affairs at Schering-Plough Corp., NJ, where he was involved in the joint venture with Merck in the clinical development of the novel cholesterol medication, ezetimibe (Zetia). Dr. Harris earned his MD from the Louis Pasteur Faculty of Medicine, University of Strasbourg, France, and his Ph.D. in endocrinology from Erasmus University, Rotterdam, The Netherlands. He was appointed Associate Professor of Medicine at UCLA School of Medicine and Director of the Division of Clinical Pharmacology in the Department of Medicine and Medical Director of the Dept of Technology Development and Transfer and Clinical Trials at Cedars-Sinai Medical Center. Dr. Harris during his tenure at Sandoz (Novartis) Pharma in Switzerland, developed octreotide (Sandostatin(R)) for the treatment of hormone producing tumors of the gut and pituitary. He is currently Adjunct Professor of Pharmacology at NYU Medical School and Visiting Professor of Medicine in the Dept of Endocrinology at Liege University Medical School, Belgium and in the Dept of Clinical Pharmacology at the University Hospital of Lausanne in Switzerland. Dr. Harris is a Fellow of the American College of Physicians, the Royal College of Physicians (UK), the Royal Society of Medicine (UK) and the American College of Clinical Pharmacology. He has served on the editorial boards of several international peer reviewed medical journals and has authored 119 peer reviewed scientific papers in the fields of endocrinology, diabetes mellitus, gastroenterology, oncology, cardiology, allergy, immunology and respiratory medicine. He served on the NIH Center for Scientific Review Special Emphasis Panel for Clinical Cardiovas
'/>"/>
SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NeoStem, Inc. Comments on Recent Selling Pressure
2. Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
3. Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years
4. Celleration Appoints Mark T. Wagner President and Chief Executive Officer
5. XLHealth Appoints New Vice President of Contracting and Provider Relations
6. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
7. Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
8. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
9. Symmetry Medical Appoints Chairman and Two Directors
10. GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director
11. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... who received hypofractionated (HPFX) radiation therapy (RT) reported ... bladder and bowel function were at similar levels ... today at the American Society for Radiation Oncology,s ... parallel quality of life outcomes occurred between groups ... RT. , The phase I/II trial enrolled 343 ...
(Date:9/16/2014)... (parous women) appear to have an increased risk ... that carries a higher mortality rate and is ... A similar relationship was found for triple-negative breast ... risk of estrogen receptor-negative and triple-negative breast cancer ... never breastfed. These findings, published in the ...
(Date:9/16/2014)... of getting prostate cancer after a worldwide team of ... genetic biomarkers, reported in Nature Genetics today. ... Jyotsna Batra and Distinguished Professor Judith Clements, who led ... hubs around the world, said the teams analysed more ... "It,s the largest analysis of genetic biomarkers ever done. ...
(Date:9/16/2014)... 16, 2014 Definitive Healthcare ... and healthcare providers, is pleased to announce the ... online database, now available for subscription, features detailed ... health system affiliations. , The Canadian database spans ... intelligence on over 750 hospitals. Each hospital ...
(Date:9/16/2014)... 16, 2014 Gary F. Locke, the ... has selected Worldwide Speakers Group for exclusive representation of ... of Commerce and Governor of Washington, Locke is widely ... U.S.-China relations, global expansion, and business growth. , “Gary ... and how to grow an organization’s global presence in ...
Breaking Medicine News(10 mins):Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 3Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Canadian Hospital Database Now Offered by Definitive Healthcare 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... by day. The number of infections a person has been ... death from heart attack. It is long been suspected that ... This has been possible by promoting inflammation within the coronary ... have conflicting evidence. ,According to researchers at University ...
... (Dietary Approaches to Stop Hypertension) says by reducing salt ... effective in decreasing blood pressure as antihypertensive medications.In addition, ... decrease in the prevalence of heart disease and a ... ,The DASH-Sodium study included 342 people. More than half ...
... to a new study the use of serotonin-raising drugs ... a stroke. In common the mecahnism of durgs is ... with many different roles in the body.// Examples include ... antidepressants. ,Researchers at the Health welfare hospital, ...
... of the American Chemical Society indicated that cooking vegetables ... our body can absorb from them.// Tung-Ching Lee, a food ... vegetables and found that 25 of them benefited from cooking ... iron content in the vegetable is the same before and ...
... amount of fruit and vegetables, but they are still only a ... a booster to our human system.On an average the percentage of ... increased from 15 per cent to18 per cent between 1993 and ... ,Among women, the percentage increase was from 20 per cent to ...
... impairment. A new hearing device that is implanted in the ... aid. Doctors say that there's now a better option for ... sound through the eardrum, and may produce feedback - distracting ... the feeling of talking within a barrel. ,The ...
Cached Medicine News:
(Date:9/16/2014)... , Sept. 16, 2014  Formex, ... manufacturing, announced that Mr. Greg Weilersbacher joined Formex ... 25, 2014. Greg Weilersbacher ... experience with focused expertise in Quality Assurance, ... Mr. Weilersbacher brings to Formex a ...
(Date:9/16/2014)... , Sept. 16, 2014 On September 25 ... exhibition focusing on medical design and manufacturing - MEDTEC ... Shanghai World Expo Exhibition & Convention Center, bringing together ... and regions to showcase their latest medical-grade raw materials, ... only one week remaining for free visitor pre-registration to ...
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
Breaking Medicine Technology:Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for ... Levodopa Tablets USP, 10mg/100mg, 25mg/100mg and 25mg/250 mg. , ... Bristol Myers Squibb,s Parkinson,s treatment Sinemet®, 10mg/100mg, 25mg/100mg and ...
... JERUSALEM, Israel, September 30 Gamida Cell ... generic,name of what is widely known as "StemEx", as ... The article, carlecortemcel-l, an ex vivo expanded,umbilical cord blood ... Chan and Dr. Demetrios Petropoulos, will be published in ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: